MarketCap
Facebook
X
Telegram
Inhibrx ROE Ratio | INBX
Annual ROE Ratio Inhibrx
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -554.81 | -250.14 | -156.1 | -100.86 | 54.93 | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 54.93 | -554.81 | -201.4 |
Quarterly ROE Ratio Inhibrx
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -853.98 | -72.78 | 733.78 | 429.87 | 753.11 | 680.13 | 532.62 | -265.82 | -151.54 | -173.89 | -124.61 | -104.5 | -72.67 | -51.12 | -10.06 | 19.99 | 46.61 | 21.55 | 18.71 | 6.35 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 753.11 | -853.98 | 68.09 |
ROE Ratio of other stocks in the Biotechnology industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Fortress Biotech
FBIO
|
74.19 | $ 1.86 | 0.82 % | $ 51.9 M |  USA |
 |
Entera Bio Ltd.
ENTX
|
-87.31 | $ 3.16 | 5.69 % | $ 146 M |  Israel |
 |
Flexion Therapeutics, Inc.
FLXN
|
682.51 | - | - | $ 459 M | USA |
 |
Legend Biotech Corporation
LEGN
|
-29.62 | $ 23.43 | 3.95 % | $ 8.64 B | USA |
 |
CytomX Therapeutics
CTMX
|
-17.54 | $ 2.19 | 2.1 % | $ 302 M | USA |
 |
Krystal Biotech
KRYS
|
16.8 | $ 300.7 | 0.15 % | $ 8.7 B | USA |
 |
Kura Oncology
KURA
|
-160.03 | $ 7.15 | 5.15 % | $ 627 M | USA |
 |
Inhibikase Therapeutics
IKT
|
-27.91 | $ 1.5 | 4.17 % | $ 147 M | USA |
 |
Heron Therapeutics
HRTX
|
-139.54 | $ 0.29 | 2.25 % | $ 48.3 M | USA |
 |
Inovio Pharmaceuticals
INO
|
-352.75 | $ 1.22 | -16.21 % | $ 57.2 M | USA |
 |
Corvus Pharmaceuticals
CRVS
|
-25.0 | $ 10.56 | 8.5 % | $ 834 M | USA |
 |
Aytu BioScience
AYTU
|
-40.4 | $ 1.82 | 0.55 % | $ 22.4 M | USA |
 |
Heat Biologics, Inc.
HTBX
|
-22.56 | - | -5.76 % | $ 99.8 M | USA |
 |
Innoviva
INVA
|
23.12 | $ 19.09 | -0.78 % | $ 1.29 B | USA |
 |
BioCardia
BCDA
|
-919.33 | $ 0.86 | -3.12 % | $ 5.73 M | USA |
 |
Kindred Biosciences, Inc.
KIN
|
-32.3 | - | 0.11 % | $ 419 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-28.65 | $ 2.44 | 9.91 % | $ 15.6 B |  Australia |
 |
Shineco, Inc.
TYHT
|
-10.15 | - | -3.90 % | $ 97.2 M |  China |
 |
Millendo Therapeutics, Inc.
MLND
|
-110.13 | - | -5.36 % | $ 20.2 M | USA |
 |
Certara
CERT
|
-0.15 | $ 12.12 | -0.53 % | $ 1.94 B | USA |
 |
Dyadic International
DYAI
|
-597.58 | $ 0.33 | -2.68 % | $ 11.9 M | USA |
 |
Intec Pharma Ltd
NTEC
|
-97.21 | - | -12.45 % | $ 17.7 M | Israel |
 |
Oramed Pharmaceuticals
ORMP
|
32.07 | $ 3.86 | -0.77 % | $ 160 M | Israel |
 |
Anika Therapeutics
ANIK
|
-7.58 | $ 14.56 | -24.68 % | $ 209 M | USA |
 |
Aprea Therapeutics
APRE
|
-101.27 | $ 0.53 | 6.6 % | $ 3.47 M | USA |
 |
Galectin Therapeutics
GALT
|
24.11 | $ 3.13 | 4.86 % | $ 200 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
15.38 | $ 72.79 | 1.62 % | $ 7.56 B | USA |
 |
Progenity, Inc.
PROG
|
179.94 | - | -3.47 % | $ 164 M | USA |
 |
Genprex
GNPX
|
-203.83 | $ 2.09 | -0.48 % | $ 1.95 M | USA |
 |
Strongbridge Biopharma plc
SBBP
|
-68.71 | - | 1.52 % | $ 136 M | USA |
 |
Innate Pharma S.A.
IPHA
|
226.58 | $ 1.43 | 2.14 % | $ 128 M |  France |
 |
Seneca Biopharma, Inc.
SNCA
|
-166.53 | - | -1.19 % | $ 28.7 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
5.73 | $ 56.03 | -0.16 % | $ 10.7 B | USA |
 |
Matinas BioPharma Holdings
MTNB
|
-214.18 | $ 1.15 | -0.86 % | $ 6.3 M | USA |
 |
Enanta Pharmaceuticals
ENTA
|
-126.53 | $ 10.99 | 9.03 % | $ 234 K | USA |
 |
Milestone Pharmaceuticals
MIST
|
-0.15 | $ 0.76 | 9.73 % | $ 80.7 M |  Canada |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
10.4 | $ 93.79 | 6.17 % | $ 6.96 B | USA |
 |
Lipocine
LPCN
|
-66.52 | $ 1.58 | 3.27 % | $ 8.61 M | USA |
 |
Seres Therapeutics
MCRB
|
12.88 | $ 1.97 | -5.74 % | $ 17.5 M | USA |
 |
Madrigal Pharmaceuticals
MDGL
|
-47.83 | $ 399.41 | -0.17 % | $ 8.96 B | USA |
 |
CEL-SCI Corporation
CVM
|
-159.25 | $ 1.44 | 6.67 % | $ 11.5 M | USA |
 |
Inventiva S.A.
IVA
|
172.73 | $ 3.8 | 4.68 % | $ 227 M | France |
 |
MeiraGTx Holdings plc
MGTX
|
1971.36 | $ 9.0 | 5.73 % | $ 724 M | USA |
 |
Processa Pharmaceuticals
PCSA
|
-243.2 | $ 1.93 | 4.89 % | $ 2.53 M | USA |
 |
Eton Pharmaceuticals
ETON
|
-17.59 | $ 56.44 | 19.7 % | $ 1.52 B | USA |
 |
IDEAYA Biosciences
IDYA
|
-11.11 | $ 31.24 | 1.92 % | $ 2.76 B | USA |
 |
Lantern Pharma
LTRN
|
-262.0 | $ 0.56 | 4.61 % | $ 6.1 M | USA |
 |
Foghorn Therapeutics
FHTX
|
68.46 | $ 1.86 | -2.62 % | $ 117 M | USA |
 |
Ocugen
OCGN
|
558.93 | $ 0.93 | 13.53 % | $ 291 M | USA |